Chou Wen-Hai, Choi Doo-Sup, Zhang Hong, Mu Dezhi, McMahon Tom, Kharazia Viktor N, Lowell Clifford A, Ferriero Donna M, Messing Robert O
Ernest Gallo Clinic and Research Center at the University of California San Francisco, Emeryville, California 94608, USA.
J Clin Invest. 2004 Jul;114(1):49-56. doi: 10.1172/JCI21655.
Thrombolysis is widely used to intervene in acute ischemic stroke, but reestablishment of circulation may paradoxically initiate a reperfusion injury. Here we describe studies with mice lacking protein kinase Cdelta (PKCdelta) showing that absence of this enzyme markedly reduces reperfusion injury following transient ischemia. This was associated with reduced infiltration of peripheral blood neutrophils into infarcted tissue and with impaired neutrophil adhesion, migration, respiratory burst, and degranulation in vitro. Total body irradiation followed by transplantation with bone marrow from PKCdelta-null mice donors reduced infarct size and improved neurological outcome in WT mice, whereas marrow transplantation from WT donors increased infarction and worsened neurological scores in PKCdelta-null mice. These results indicate an important role for neutrophil PKCdelta in reperfusion injury and strongly suggest that PKCdelta inhibitors could prove useful in the treatment of stroke.
溶栓疗法被广泛用于干预急性缺血性中风,但循环重建可能反常地引发再灌注损伤。在此,我们描述了对缺乏蛋白激酶Cδ(PKCδ)的小鼠进行的研究,结果显示该酶的缺失显著减轻了短暂性缺血后的再灌注损伤。这与外周血中性粒细胞向梗死组织的浸润减少以及体外中性粒细胞的黏附、迁移、呼吸爆发和脱颗粒受损有关。全身照射后移植来自PKCδ基因敲除小鼠供体的骨髓可减小野生型小鼠的梗死面积并改善神经功能结局,而来自野生型供体的骨髓移植则会增加PKCδ基因敲除小鼠的梗死面积并恶化神经功能评分。这些结果表明中性粒细胞PKCδ在再灌注损伤中起重要作用,并强烈提示PKCδ抑制剂可能对中风治疗有用。